CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project addresses the challenges of treating glioblastoma multiforme, a highly aggressive brain tumor, using nanotechnology. It focuses on delivering drug-loaded nanoparticles to the tumor site, enhancing treatment efficacy through targeted drug release and hyperthermia.
Central nervous system (CNS) tumors are an important cause of morbidity and mortality worldwide.
Among them, glioblastoma multiforme (GBM) is the most aggressive and lethal, characterized by extensive infiltration into the brain parenchyma.
Under the standard treatment protocols, GBM patients can expect a median survival of 14.6 months, while less than 5% of patients live longer than 5 years.
This poor prognosis is due to several factors, including the highly aggressive and infiltrative nature o…
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Torino
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
